Immunofluorescense of skin tissues: Difference between revisions

From patholines.org
Jump to navigation Jump to search
Mikael Häggström (talk | contribs)
+Indications
 
Mikael Häggström (talk | contribs)
+Composition
Line 4: Line 4:
}}
}}
==Indications==
==Indications==
Suspicion of one or several '''immunologic diseases''':<ref name="ChhabraMinz2012">Page 678 in: {{cite journal|last1=Chhabra|first1=Seema|last2=Minz|first2=RanjanaWalker|last3=Saikia|first3=Biman|title=Immunofluorescence in dermatology|journal=Indian Journal of Dermatology, Venereology, and Leprology|volume=78|issue=6|year=2012|pages=677|issn=0378-6323|doi=10.4103/0378-6323.102355|url=https://pdfs.semanticscholar.org/23d0/148dbe342a93e0bc65a6a2e31040a89113ba.pdf}}</ref> Fixation for immunofluorescence, with for example [[Michel's solution]].<ref name=kvast>{{cite web|url=http://www.svfp.se/foreningar/uploads/L15178/kvast/hud/Handlaggning%20av%20hudprover%20%20provtagningsanvisningar%20utskarningsprinciper%20och%20snittning%2020150325.pdf|title=Handläggning av hudprover – provtagningsanvisningar, utskärningsprinciper och snittning (Handling of skin samples - Instructions for sampling, cutting and incision|author=Katarzyna Lundmark, Krynitz, Ismini Vassilaki, Lena Mölne, Annika Ternesten Bratel|accessdate=2019-09-09|website=KVAST (Swedish Society of Pathology)}}</ref>
Suspicion of one or several '''immunologic diseases''':<ref name="ChhabraMinz2012">Page 678 in: {{cite journal|last1=Chhabra|first1=Seema|last2=Minz|first2=RanjanaWalker|last3=Saikia|first3=Biman|title=Immunofluorescence in dermatology|journal=Indian Journal of Dermatology, Venereology, and Leprology|volume=78|issue=6|year=2012|pages=677|issn=0378-6323|doi=10.4103/0378-6323.102355|url=https://pdfs.semanticscholar.org/23d0/148dbe342a93e0bc65a6a2e31040a89113ba.pdf}}</ref>  


Suspected conditions where the direct immunofluorescence (DIF) is diagnostic:<ref name="ChhabraMinz2012"/>
Suspected conditions where the direct immunofluorescence (DIF) is diagnostic:<ref name="ChhabraMinz2012"/>
Line 51: Line 51:
*ANCA associated SVV
*ANCA associated SVV


==Fixation==
For example ''Michel's solution'',<ref name=kvast>{{cite web|url=http://www.svfp.se/foreningar/uploads/L15178/kvast/hud/Handlaggning%20av%20hudprover%20%20provtagningsanvisningar%20utskarningsprinciper%20och%20snittning%2020150325.pdf|title=Handläggning av hudprover – provtagningsanvisningar, utskärningsprinciper och snittning (Handling of skin samples - Instructions for sampling, cutting and incision|author=Katarzyna Lundmark, Krynitz, Ismini Vassilaki, Lena Mölne, Annika Ternesten Bratel|accessdate=2019-09-09|website=KVAST (Swedish Society of Pathology)}}</ref> minimally consisting of ammonium sulfate and saline.<ref>{{cite journal|last1=Niedecken|first1=Heinz W.|last2=Lange|first2=Claus-Ekkehard|title=Simplified fixative medium for direct immunofluorescence in skin biopsies|journal=Journal of the American Academy of Dermatology|volume=12|issue=5|year=1985|pages=828–831|issn=01909622|doi=10.1016/S0190-9622(85)70103-X}}</ref>
{{Bottom}}
{{Bottom}}

Revision as of 05:41, 17 September 2019

Author: Mikael Häggström [note 1]

Indications

Suspicion of one or several immunologic diseases:[1]

Suspected conditions where the direct immunofluorescence (DIF) is diagnostic:[1]

  • Bullous diseases
  • Pemphigus (all forms)
  • Pemphigoid (all forms)
  • Herpes gestationis/gestational pemphigoid
  • Dermatitis herpetiformis
  • Linear IgA bullous dermatosis Epidermolysis bullosa aquisita
  • Connective tissue diseases
  • Discoid lupus erythematosus
  • Systemic lupus erythematosus

Suspected conditions where DIF is highly characteristic and of some value:[1]

  • Vascular diseases
  • Allergic vasculitis
  • Henoch–Schoenlein purpura
  • Essential mixed cryoglobulinemia
  • Polyarteritis nodosa
  • Porphyria
  • Especially porphyria cutanea tarda
  • Lichen planus

Conditions where DIF is not diagnostic but only suggestive of immunologic pathogenesis:[1]

  • Connective tissue diseases
  • Mixed connective tissue diseases
  • Systemic sclerosis
  • Dermatomyositis
  • Psoriasis

Suspected conditions where indirect immunofluorescence is generally indicated:[1]

  • Pemphigus vulgaris
  • Pemphigus foliaceus
  • IgA pemphigus
  • Bullous pemphigoid
  • Dermatitis herpetiformis
  • Discoid lupus erythematosus
  • Disseminated DLE
  • Systemic lupus erythematosus
  • Scleroderma
  • Mixed connective tissue diseases
  • Dermatomyositis
  • Vasculitis[notes 1]
  • Porphyria[notes 1]
  • Lichen planus[notes 1]
  • ANCA associated SVV

Fixation

For example Michel's solution,[2] minimally consisting of ammonium sulfate and saline.[3]

Notes

  1. 1.0 1.1 1.2 Sometimes used to rule out SLE by absence of anti-nuclear antibodies in uncertain cases
  1. For a full list of contributors, see article history. Creators of images are attributed at the image description pages, seen by clicking on the images. See Patholines:Authorship for details.

Main page

References

  1. 1.0 1.1 1.2 1.3 1.4 Page 678 in: Chhabra, Seema; Minz, RanjanaWalker; Saikia, Biman (2012). "Immunofluorescence in dermatology ". Indian Journal of Dermatology, Venereology, and Leprology 78 (6): 677. doi:10.4103/0378-6323.102355. ISSN 0378-6323. Archived from the original. . 
  2. Katarzyna Lundmark, Krynitz, Ismini Vassilaki, Lena Mölne, Annika Ternesten Bratel. Handläggning av hudprover – provtagningsanvisningar, utskärningsprinciper och snittning (Handling of skin samples - Instructions for sampling, cutting and incision. KVAST (Swedish Society of Pathology). Retrieved on 2019-09-09.
  3. Niedecken, Heinz W.; Lange, Claus-Ekkehard (1985). "Simplified fixative medium for direct immunofluorescence in skin biopsies ". Journal of the American Academy of Dermatology 12 (5): 828–831. doi:10.1016/S0190-9622(85)70103-X. ISSN 01909622. 

Image sources